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ABSTRACT 
Objectives: The objective of this research was to compare the anti-inflammatory activity of aqueous and methanolic extracts of C. cassia (CC) and C. 
zeylanicum (CZ) in mouse macrophage (RAW264.7) and human chondrosarcoma (SW1353) cell lines as well as in human primary chondrocytes, to 
correlate their efficacy in management of osteoarthritis (OA) related pathophysiology. 
Methods: RAW264.7, SW1353 and human primary chondrocytes were pre-treated with aqueous extracts of C. cassia (CCW) and C. zeylanicum (CZW) 
and methanolic extracts of C. cassia (CCM) and C. zeylanicum (CZM) at various concentrations (0.1-100 µg/ml) for 1 h, followed by stimulation with 
LPS and IL-1β, respectively. The effect of CCM, CCW, CZM and CZW on the production of nitric oxide (NO) was evaluated by Griess reaction. Evaluation 
of prostaglandin E2 (PGE2) and leukotriene (LTB4) proteins was performed by EIA-Monoclonal based kits. The effect of these extracts on matrix 
metalloproteinase (MMPs-2, 9 and 13) levels was analyzed by SensoLyte® fluorimetric MMP assay kit. 
Results: The methanolic extracts (CCM, CZM) of both the varieties of cinnamon were found to be more effective than the aqueous extracts in terms of 
PGE2, LTB4 and MMP inhibition. We found that in RAW 264.7, CCM and CZM decreased NO and PGE2 production by 45.4%±8.6; 65.6%±5.7 and 
79.8%±1.2; 95.9%±0.3, respectively. Similarly, in SW1353 and chondrocytes, CCM decreased PGE2 production by 68.8%±6.4;36.1%±9.5, respectively 
whereas CZM reduced PGE2 production by 70.2%±2.3; 52.3%±5.4, respectively. Moreover, in SW1353 and chondrocytes CCM decreased LTB4 
production by 85.47%±3.03; 99.6%±0.2, respectively whereas CZM reduced LTB4 production by 67.5%±5.6; 75.6%±1.2, respectively. In 
chondrocytes both CCM and CZM significantly reduced the levels of MMP-2(55.7%±5.2; 73.1%±7.1), MMP-9 (57.5%±4.7; 74.5%±5.2) and MMP-13 
(90.1%±2.6; 71.2%±12.5), respectively. However, on comparing the two species of cinnamon, C. zeylanicum was found to be more effective than C. 
cassia and thus could be considered for its potential therapeutic application in the management of inflammatory conditions associated with OA. 
Conclusion: The present study would help in choosing better of the two species of cinnamon for their possible therapeutic application in the 
management of inflammatory condition associated with OA. 
Keywords: C. cassia, C. zeylanicum, Inflammation, Osteoarthritis, Chondrocytes.  
 
Cinnamon is widely used as a culinary spice and flavoring agent [1]. It 
has been extensively used in Indian traditional medicine for the 
management of various disease conditions [2]. Various studies have 
shown that Cinnamon has anti-inflammatory properties and decreased 
the expression of the inflammatory markers such as interleukin (IL)-1β, 
IL-6 and Tumor necrosis factor (TNF)-α [3]. Although there are many 
types of Cinnamon, only four varieties that are used for commercial 
purposes include C. zeylanicum, C. cassia, C. saigon and C. korintje. C. 
cassia (CC), is widely used as traditional Chinese medicine for treating 
blood circulation disturbances, gastritis and inflammatory diseases [4]. 
It has been shown to have various pharmacological properties, such as 
antiulcerogenic [5], anti-inflammatory [6], antipyretic [7], antimicrobial 
[8], antidiabetic [9] and antitumor activity [10]. Cinnamaldehyde, the 
active component of cinnamon, has been reported to down regulate the 
production of major inflammatory mediators such as inducible nitric 
oxide synthase (iNOS), cyclooxygenase (COX)-2, nuclear factor kappa 
(NF-κB) in RAW264.7 cells [11, 12]. C. zeylanicum (CZ), has been used 
traditionally for its anti-diabetic [13], anti-nociceptive [14], astringent 
[15] and diuretic activities [15]. Procyanidine polyphenols, a compound 
extracted from CZ has been reported to regulate inflammation and 
arthritis [16]. Gunawardena et al., (2015) has recently demonstrated the 
anti-inflammatory activity of cinnamon (CZ and CC) extracts as well as its 
phytochemical compounds (E-cinnamaldehyde and o-methoxy 
cinnamaldehyde) in vitro [17]. Hong et al., (2012) demonstrated that 
administration of water extract of cinnamon in vivo decreased the serum 
levels of TNF-α and IL-6. At in vitro level, it was shown to decrease the 
expression of TNF-α, inhibit LPS-induced degradation of IκBα as well as 
activate JNK, p38 and ERK1/2 [18].  
Although several studies have reported anti-inflammatory activity of 
cinnamon bark from either CC or CZ, however, their efficacy in the 
management of osteoarthritis (OA) associated pathophysiology has 
not been compared. In the present work, we have for the first time 
compared the effect of two varieties of cinnamon on modulation of 
NO, PGE2, LTB4 and MMP levels in human chondrocytic cell line 
(SW1353) and human primary chondrocytes. Such studies would 
help in selection of important medicinal plants that could be used for 
the prevention, cure and management of OA related pathogenesis. 
We found that compared to the aqueous extracts, the methanolic 
extract of C. cassia and C. zeylanicum significantly modulated NO, 
PGE2, LTB4 and MMP levels in the tested cells. However, CZ proved 
to exhibit higher efficacy than CC and thus could be explored in the 
management of OA.  
The materials used in the study included DMEM, L-15 media, Hams 
F12, FBS, penicillin and streptomycin, lipopolysaccharide (LPS), 
IL-1β, dexamethasone, 1400W dihydrochloride and (3-4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
were purchased from Sigma-Aldrich (St. Louis, MO, USA), L-
glutamine was purchased from Himedia Corporation, Mumbai, 
India). MMP kit was purchased from Cisbio, PGE2 and LTB4 kits 
were purchased from Cayman and tissue culture plasticware was 
purchased from BD Biosciences (San Diego, CA, USA).  
The extracts of the barks of C. cassia and C. zeylanicum were 
procured from Natural Remedies, Pvt. Ltd. Bangalore. The plant 
materials were identified by National Institute of Science 
Communication and Information Resources (NISCAR), New Delhi 
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and Dr. P. Santhan, in-house taxonomist, Pharmacognosy 
department, R&D center, Natural Remedies Pvt. Ltd, Bangalore, 
India. The barks were sundried and stored. Voucher specimens 
(NRPL-569 and 570) were deposited in the herbarium of Natural 
Remedies, Pvt. Ltd. Bangalore. 
For the preparation of CCM and CZM, the coarsely powdered raw 
material (50 g) was extracted with methanol (~200 ml) under 
reflux at 70oC for 1h and the solvent was filtered. The remaining 
raw material was refluxed by adding 150 ml methanol for 1 h, 
repeated twice and again filtered. The liquid filtrate was 
combined and concentrated using rotavapor under vacuum to a 
thick paste at temperature NMT 60 oC and 10.0 g of crude extract 
was obtained. For the preparation of CCW and CZW, the coarsely 
powdered raw material (50 g) was mixed with water and 
extracted at 85 to 90oC (3 times each with 200 ml water for 1 h 
each wash) and filtered each time. The combined liquid filtrates 
were concentrated using rota vapor under vacuum to a thick 
paste at temperature NMT 60oC and 15.0 g of crude water extract 
was obtained [19].  
The cell lines RAW264.7 and SW1353 were purchased from 
American Type Culture Collection (ATCC, USA). The cell lines were 
maintained in DMEM and L-15 media containing 2 mM L-
glutamine, respectively, (Himedia Corporation, Mumbai, India) 
supplemented with 10% FBS (Sigma, St. Louis, MO, USA), 
20Units/ml penicillin and 20 µg/ml streptomycin (Gibco BRL, 
USA). Human cartilage sample was obtained from the patient 
undergoing knee replacement surgery after approval from 
institutional ethics committee (IEC) of Bharati Vidyapeeth Medical 
College (Ref: BVDU/MC/55) and informed consent from the 
patient. Chondrocytes were prepared by the enzymatic digestion 
of cartilage with 0.25% collagen and plated (1 × 106 cells/ml) in 35 
mm primaria coated culture dishes. The cells were cultured in 
DMEM: Hams (1:1) F12 containing 2 mM L-glutamine, 10% FBS, 
100Units/ml penicillin and 100 µg/ml streptomycin and incubated 
in 5% CO2 incubator at 37 °C.  
For cell viability assay, RAW264.7, SW1353 and human primary 
chondrocytes were seeded at a density of 5x105cells/ml in 96-well 
plates. The cells were treated with different concentrations (0-100 
µg/ml) of CCM, CCW, CZM and CZW for 24 h. Cell viability was 
determined by MTT assay as described previously [20, 21]. 
For evaluating nitric oxide (NO) release, RAW 264.7 cells were 
seeded at a density of 5x105cells/ml in 96 well plate and allowed to 
adhere for 24 h. The cells were pre-treated with different 
concentrations (0-100 µg/ml) of CCM, CCW, CZM and CZW for 1h, 
followed by stimulation with 1 µg/ml of LPS for 18 h. The amount of 
nitrite released was measured as described previously [21].  
For PGE2 and LTB4 assays, RAW 264.7 cells, SW1353 and human 
primary chondrocytes were seeded at a density of 5x105cells/ml in 
96 well plate and allowed to adhere for 24 h. RAW 264.7 cells were 
pre-treated with CCM, CCW, CZM and CZW as described above. SW1353 
and human chondrocytes were starved for 18 h in L-15 media 
containing 0.25% FBS and 1:1 DMEM/Hams F-12 respectively, prior 
to treatment with the test samples. The cells were pre-treated with 
different concentrations (0-100 µg/ml) of CCM, CCW, CZM and CZW 
followed by stimulation with 10 ng/ml of IL-1β for 18 h. PGE2 
concentration was determined in the cell supernatants by using 
PGE2 EIA-Monoclonal based kits (Cayman Co., Ann Arbor, Mich., 
USA). LTB4 levels were determined in the supernatant by using 
LTB4 EIA-Monoclonal based kits, (Cayman Co., Ann Arbor, Mich., 
USA). For evaluating MMP levels, human chondrocytes were starved 
for 18 h and pre-treated with CCM, CCW, CZM and CZW as described 
above. MMPs (2, 9, and 13) were quantified in the supernatant by 
using commercial SensoLyte® 520 Generic MMP Activity Kit (Cysbio 
Anaspec Eurogentec group, USA). 
For statistical analysis, all the experiments were performed in 
triplicates and the values have been presented as mean±SD. 
Differences among means were tested for statistical significance 
using one-way analysis of variance (ANOVA). For multiple 
comparisons,Tukeys test was used. The analyses were carried out 
using Graph-pad prism 5 software (San Diego, CA, USA). *p<0.05; 
**p<0.01; ***p<0.001 were considered to be statistically significant. 
Raw264.7, SW1353 and human chondrocytes were treated with 
different concentrations of extracts (0-100 μg/ml) to test their effect 
on cell viability. CCM and CCW (table 1a); as well as CZM and CZW 
(table 1b) were found to be non-toxic to the cells, thereby suggesting 
them to be safe for use in further studies. 
 
Table 1a: Effect of CCM and CCW on cell viability in RAW264.7, SW1353, human primary chondrocytes 
 CCM CCW 
Concentration of extracts 
(μg/ml) 
RAW264.7 SW1353 human primary 
chondrocytes 
RAW264.7 SW1353 primary human 
chondrocytes 
0.1 101.1±1.4 100.2±0.1 100.4±0.3 101.4±2.3 102.7±3.4 101.8±2.4 
1 100.1±0.8 100.1±0.04 100.1±0.1 101.8±2.5 103.6±3.6 104.3±0.9 
10 100.2±0.8 100.0±0.2 100.8±0.4 100.7±0.7 105.8±3.1 109.7±3.3 
100 100.5±0.5 102.8±2.5 104.0±1.1 100.8±0.8 104.3±1.1 112.0±1.7 
Values have been represented as mean±SD of three independent experiments. 
 
Table 1b: Effect of CZM and CZW on cell viability in RAW264.7, SW1353, human primary chondrocytes 
 CZM CZW 
Concentration of extracts 
(μg/ml) 
RAW264.7 SW1353 human primary 
chondrocytes 
RAW264.7 SW1353 primary human 
chondrocytes 
0.1 100.1±0.1 100.0±0.01 100.4±0.4 102.1±1.4 101.06±1.4 100.05±0.04 
1 100.7±0.9 102.1±1.3 102.0±0.5 104.6±0.9 101.04±0.1 101.6±0.6 
10 101.8±1.9 101.8±1.9 110.2±2.2 106.8±2.1 105.06±2.0 108.02±0.7 
100 105.4±4.3  104.3±0.5 118.6±0.8 109.9±0.7 105.6±0.7 115.5±1.1 
Values have been represented as mean±SD of three independent experiments.  
 
Raw264.7 cells were treated with different concentrations of CCM, CCW, CZM and CZW (0-100 µg/ml). A significant dose dependent decrease in nitrite 
production was observed with both the extracts as compared to LPS stimulated control cells. We found that at 100 µg/ml dose, CCM exhibited 45.4 % 
(p<0.001) decrease in NO levels compared to CCW (24.7 %; p<0.001) (table 2). At the same dose, CZM effectively reduced the NO levels by 65.6 % 
(p<0.001) compared to CZW (28.67 %; p<0.001) (table 2). The results showed that CCM and CZM effectively reduced NO levels compared to their 
respective aqueous extracts. 
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Table 2: Effect of CCW, CCM, CZW and CZM on NO levels in LPS stimulated RAW264.7 
Concentration of extracts (μg/ml) CCW CCM CZW CZM 
  % decrease in NO levels 
0.1 5.2±4.5 5.7±4.9 7.4±3.8 14.8±8.4 
1 11.5±5.4 9.5±3.8 14.9±9.2 19.7±4.5 
10 12.7±9.1 23.1±6.9 18.4±7.1 48.3±7.6 
100 24.7±6.1 45.4±8.6a 28.7±6.7c 65.6±5.7b 
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap<0.05 compared to CCW, bp<0.01 
compared to CZW, bp<0.05 compared to “a”, cp>0.05 compared to CCW 
 
We compared the effect of CCM, CCW, CZM and CZW on PGE2 levels in 
RAW264.7, SW1353 and primary human chondrocytes. Since the 
extracts induced maximum inhibition in the nitrite levels in 
RAW264.7 cells at 100µg/ml dose, this dose was selected for our 
further experiments. It was observed that at 100 µg/ml dose, CCM 
and CCW reduced the PGE2 production by 79.8 % (p<0.001) and 
80.1 % (p<0.001), respectively in RAW264.7 cells. At the same 
dose, CZM reduced PGE2 levels by 95.9 % (p<0.001), compared to 
CZw (11.2 %) (table 3). Both the extracts of CC seemed to be 
equally effective in reducing PGE2 levels in RAW264.7 cells. In IL-
1β stimulated SW1353 cells, at 100µg/ml dose, CCM significantly 
reduced PGE2 production by 68.8 % (p<0.001) compared to CCw 
(22.36 %; p<0.001) whereas CZM was found to decrease PGE2 
production by 70.2 % (p<0.001) compared to CZw (59.93 %; 
p<0.001) (table 3). Interestingly, in human primary chondrocytes, 
the methanolic extracts of cinnamon reduced PGE2 levels more 
effectively compared to the aqueous extracts. At 100µg/ml dose, 
CCM reduced PGE2 production by 36.1 % (p<0.01), compared to 
CCW (6.7 %) whereas CZM decreased the PGE2 production by 52.3 % 
(p<0.001), compared to CZW (16.2%) (table 3). The data showed 
that CCM and CZM reduced PGE2 levels significantly in chondrocytic 
cell line and primary chondrocytes. 
  
Table 3: Effect of CCW, CCM, CZW and CZM on PGE2 levels in RAW264.7, SW1353 cells and primary human chondrocytes 
 % decrease in PGE2 levels 
Concentration of extracts (100μg/ml) RAW264.7 SW1353 primary human chondrocytes 
CCW 80.1±3.8 22.4±20.7 6.7±4.2 
CCM 79.8±1.2a 68.8±6.4d 36.1±9.5g 
CZW 11.2±11.6c 59.9±4.8f 16.2±3.7i 
CZM 95.9±0.3b 70.2±2.3e 52.3±5.4h 
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap>0.05 compared to CCW, 
bp<0.001 compared to CZW, bp<0.001 compared to “a”, cp<0.001 compared to CCW, dp<0.05 compared to CCW, ep>0.05 compared to CZW, ep>0.05 
compared to “d”, fp<0.05 compared to CCW, gp<0.05 compared to CCW, hp<0.05 compared to CZW, hp>0.05 compared to “g”, ip>0.05 compared to CCW 
 
CCM, CCW, CZM and CZW were further compared for their potential to 
modulate IL-1β induced LTB4 production in SW1353 and human 
chondrocytes. In SW1353, at 100µg/ml dose, CCM reduced LTB4 
levels by 85.5 % (p<0.001) compared to CCW (61.6 %; p<0.001) 
(table 4). At the same dose CZM reduced LTB4 by 67.5 % (p<0.001) 
as compared to CZW (26.8 %; p<0.001). In human primary 
chondrocytes, at 100µg/ml dose, both CCM and CCW significantly 
reduced the LTB4 levels by 99.6 % (p<0.001) and 90.27 % 
(p<0.001), respectively. On the other hand, CZM reduced LTB4 levels 
by 75.6 % (p<0.001) compared to CZW (48.8 %; p<0.001) (table 4). 
Thus, CCM and CZM showed more decrease in LTB4 production 
compared to the aqueous extracts. 
  
Table 4: Effect of CCW, CCM, CZW and CZM on LTB4 levels in SW1353 cells and primary human chondrocytes 
Concentration of extracts (100μg/ml) % Decrease in LTB4 levels 
SW1353 primary human chondrocytes 
CCW 61.6±4.6 90.3±0.1 
CCM 85.5±3.0a 99.6±0.2d 
CZW 26.8±6.1c 48.8±0.9f 
CZM 67.5±5.6b 75.6±1.2e 
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap<0.05 compared to CCW, bp<0.01 
compared to CZW, bp>0.05 compared to “a”, cp<0.01 compared to CCW, dp<0.01 compared to CCW, ep<0.001 compared to CZW, ep<0.001 compared to 
“d”, fp<0.001 compared to CCW 
 
We compared the effect of CCM, CCW and CZM, CZW on IL-1β 
induced MMP levels in primary chondrocytes. Compared to 
control stimulated cells, at 100µg/ml dose, CCM reduced MMP 2, 
9 and 13 production by 55.7 % (p<0.001), 57.5 % (p<0.001) and 
90.1 % (p<0.001), respectively. At the same dose, CCW reduced 
MMP 2, 9 and 13 production by 16.1 %, 59.5 % (p<0.001) and 
41.5 % (p<0.001), respectively (table 5). Similarly, at 100µg/ml 
dose, CZM significantly decreased MMP 2, 9 and 13 production by 
73.1 % (p<0.001), 39 % (p<0.001) and 71.2 % (p<0.001), 
respectively, whereas CZW reduced MMP 2, 9 and 13 production 
by 15.6 %, 6.4 % and 40.1 % (p<0.01), respectively, compared to 
the control cells (table 5). Altogether, the data showed that 
methanolic extracts significantly reduced MMP levels compared 
to the aqueous extracts, however with few exceptions. 
The present study compared the anti-inflammatory activity of 
aqueous and methanolic extracts of C. cassia and C. zeylanicum in 
RAW264.7, SW1353 and human primary chondrocytes. We found 
that in LPS activated RAW264.7 cells, CCM, CZM attenuated NO 
release more significantly than CCW, CZW. NO is a signalling molecule 
implicated in a broad spectrum of pathophysiological processes such 
as inflammation, apoptosis, regulation of enzyme activity and gene 
expression [22]. In an earlier study, it had been reported that the 
water extract of CC could not inhibit LPS-induced NO production in 
RAW 264.7 cells at 100 µg/ml concentration [25]. Interestingly, we 
found that at 100 µg/ml dose, CCW significantly inhibited LPS-
induced NO production in RAW 264.7 cells. The difference in these 
results could be attributed to the method of preparation of the 
extracts, source variation, time of collection of the material and so on 
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that may affect the presence of phytoactives in the extract, which 
contribute to their biological activity. Elevated levels of NO have 
been reported to play a critical role in the aggravation of chronic 
inflammatory conditions such as osteoarthritis [22-24]. Therefore, 
reducing NO production would be an important therapeutic target in 
the development of anti-inflammatory agents. 
 
Table 5: Effect of CCW, CCM, CZW and CZM on MMP levels in primary human chondrocytes 
Concentration of extracts (100μg/ml) Primary human chondrocytes  
% decrease in MMP levels 
MMP-2 MMP-9 MMP-13 
CCW 16.1±17.0 59.5±4.2 41.5±7.8 
CCM 55.7±5.2a 57.5±4.7d 90.1±2.6g 
CZW 15.6±22.1c 6.4±3.2f 40.1±5.7i 
CZM 73.1±7.1b 74.5±5.2e 71.2±12.5h 
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap>0.05 compared to CCW, bp>0.05 
compared to CZW, bp>0.05 compared to “a”, cp>0.05 compared to CCW, dp>0.05 compared to CCW, ep<0.001 compared to CZW, ep>0.05 compared to 
“d”, fp<0.001 compared to CCW, gp<0.01 compared to CCW, hp>0.05 compared to CZW, hp>0.05 compared to “g”, ip>0.05 compared to CCW  
 
It was further observed that CCM and CZM effectively decreased PGE2 
production in RAW264.7, SW1353 and human primary 
chondrocytes compared to the aqueous extracts. However, CZM was 
found to be more effective than CC in reducing PGE2 production. 
PGE2 is an important inflammatory mediator and is produced from 
arachidonic acid metabolites by the catalysis of COX-2. It is one of 
the major catabolic mediators involved in cartilage degradation and 
chondrocyte apoptosis [26]. The water extract of CC was earlier 
shown to decrease PGE2 production by almost 34% at 100 µg/ml 
concentration in RAW 264.7 cells, [25] whereas our study showed 
almost 80% reduction in PGE2 production at the same concentration 
of the extract. Moreover, we have analysed the effect of the extracts 
on PGE2 production in SWI353 and primary chondrocytes as well. 
OA cartilage spontaneously releases more PGE2 than the normal 
cartilage [27, 28]. Thus, blocking of PGE2 production by cinnamon in 
OA could be a promising strategy in preventing cartilage 
degradation and chondrocyte apoptosis.  
In SW1353, the methanolic extracts of CC and CZ reduced LTB4 
levels more effectively than the aqueous extracts. In primary human 
chondrocytes, CCW, CCM induced an enhanced decrease in LTB4 
levels that went below the basal values and hence needs careful 
evaluation. Since LTB4 is involved in a number of important cellular 
processes in the body [29] and its down regulation below the basal 
level may lead to severe complications [30-32].  
However, CZM effectively reduced LTB4 levels than CCW. Thus, CZ 
appears to be better option than CC in terms of LTB4 inhibition as it 
does not reduce LTB4 below the basal values. LTB4 plays a direct 
role in OA pathogenesis. Its increased synthesis has been found in 
the synovial tissue and synovial fluid of patients with OA. Thus, 
reducing LTB4 production in OA could help in modulating the 
pathophysiological conditions associated with this disease. 
CCM and CZM effectively decreased the levels of MMPs 2, 9 and 13 
compared to CCW, CZW. In human chondrocytes, MMPs are 
synthesized and secreted by chondrocytes in response to cytokines. 
The expression of gelatinases (MMP-2 and MMP-9) is either low or 
absent in most normal tissues, and markedly elevated during 
inflammation [33]. MMP-13 is secreted by chondrocytes in response 
to cytokines (IL-1β), causing digestion of type II collagen in cartilage 
[34]. It has also been reported to be associated with cartilage 
hypertrophy and calcification [35]. Thus, modulating the expression 
of MMPs 2, 9 and 13 by CCM and CZM could prevent continued 
degradation of articular cartilage.  
Compared to the aqueous extracts of cinnamon, the methanolic 
extracts significantly reduced the production of NO, PGE2, LTB4 and 
MMPs. C. cassia has been reported to contain high amounts of 
coumarins, which may cause liver damage [36] whereas C. 
zeylanicum hardly contains any coumarin [36]. On comparing the 
two species of cinnamon, C. zeylanicum appears be a better modifier 
of the inflammatory cascade in OA related pathology. Thus, CZM 
could be proposed for its use in the modulation of major 
inflammatory mediators in OA, which would help in the regulation of 
chondrocyte survival, production of pro-inflammatory cytokines, 
prostaglandins, leukotrienes and production of ECM degrading 
enzymes such as MMPs.  
In conclusion, these results suggested that compared to CC, CZ 
exhibited excellent anti-inflammatory activity through suppression 
of NO, PGE2, LTB4 and MMP production. Due to the serious side-
effects associated with the use of NSAIDs, the focus of drug 
industries has shifted towards towards evaluation of anti-
inflammatory activity of medicinal plants that are rich in 
phytochemicals. The search for natural products that would regulate 
the inflammatory cascade associated with OA without affecting 
chondrocytes survival is of pivotal importance. This work is a small 
step towards comparing the natural products that would not only be 
effective in managing OA but would also be safe for chondrocyte 
health, which in turn would protect the degradation of cartilage. 
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